EGM
MREO

Engineers Gate Manager’s Mereo BioPharma MREO Stock Holding History

Engineers Gate Manager’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.61K Sell
23,953
-1
-0% – ﹤0.01% 2189
2026
Q1 		$7.91K Sell
23,954
-25,844
-52% -$11.1K ﹤0.01% 2137
2025
Q4 		$20.8K Buy
+49,798
New +$94.8K ﹤0.01% 2025

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Engineers Gate Manager's MREO Position: Q2 2026 in Review

Engineers Gate Manager reduced its Mereo BioPharma (MREO) stake by 0% in Q2 2026, cutting 1 share and leaving 23,953 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Engineers Gate Manager first reported a position in MREO in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.8K in Q4 2025. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Engineers Gate Manager held 23,953 shares of Mereo BioPharma worth $7.61K as of Q2 2026.
  • Engineers Gate Manager sold 1 Mereo BioPharma share in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2189 holding.
  • Engineers Gate Manager first reported a position in Mereo BioPharma in Q4 2025 and has held it in 3 quarters since.
  • Engineers Gate Manager's Mereo BioPharma position peaked at $20.8K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.